What is the recommended management and follow-up for a patient with multiple benign-appearing skin lesions similar to seborrheic keratosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Benign-Appearing Seborrheic Keratosis Lesions

For clinically benign-appearing seborrheic keratosis lesions without concerning features, biopsy is not necessary, and annual skin surveillance is appropriate. 1

Clinical Decision-Making for These Lesions

When Biopsy is NOT Required

Your clinical assessment appears sound. Lesions that are clinically consistent with seborrheic keratosis and lack warning signs do not require biopsy. 2 The key is ensuring none of the following concerning features are present:

Major warning signs to exclude (the "7-point checklist"): 2

  • Change in size
  • Change in shape
  • Change in color
  • Diameter ≥ 7 mm
  • Inflammation
  • Sensory change (itching, tenderness)
  • Crusting or bleeding

When Biopsy IS Required

Complete excision with a 2 mm margin of normal skin should be performed if: 1, 3, 2

  • Any of the above warning signs are present
  • The lesion has irregular borders, asymmetry, or heterogeneous pigmentation (ABCDE criteria) 1
  • Clinical uncertainty exists about the diagnosis
  • The lesion fails to respond to treatment (if treatment were attempted) 1

Critical pitfall: Melanoma can mimic seborrheic keratosis, as can pigmented basal cell carcinoma. 1, 3 Visual assessment alone has documented cases of misdiagnosis. 2 However, when lesions are clinically typical for seborrheic keratosis without concerning features, observation is appropriate.

Recommended Follow-Up Strategy

Annual skin surveillance is appropriate for patients with multiple seborrheic keratoses. 1 This recommendation is based on:

  • Seborrheic keratoses themselves are benign and do not transform into malignancy 1
  • However, their presence indicates chronic sun exposure, which is a risk factor for skin cancer 1
  • Patients with multiple benign lesions benefit from periodic surveillance to detect any new or changing lesions that may represent actual malignancy 1

Patient Education Components

Educate the patient to monitor for and report: 1

  • New lesions developing
  • Any existing lesion showing change in size, shape, or color
  • Development of irregular borders or pigmentation
  • Symptoms such as itching, bleeding, or crusting
  • Any lesion that "looks different" from the others

Sun protection counseling is essential given that multiple seborrheic keratoses indicate significant cumulative sun exposure, which increases melanoma and non-melanoma skin cancer risk. 1

Documentation Recommendations

Your documentation should include: 1

  • Location of lesions (you've done this appropriately)
  • Clinical appearance consistent with seborrheic keratosis
  • Absence of concerning features
  • Patient education provided regarding warning signs
  • Plan for annual surveillance

This approach balances avoiding unnecessary biopsies of benign lesions (which carry cost and morbidity) while maintaining appropriate vigilance for malignancy. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Seborrheic Keratosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic and Management Considerations for Skin Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.